Characterization of the mechanism of drug-drug interactions from PubMed using MeSH terms

被引:20
作者
Lu, Yin [1 ]
Figler, Bryan [1 ]
Huang, Hong [2 ]
Tu, Yi-Cheng [3 ]
Wang, Ju [4 ]
Cheng, Feng [1 ,5 ]
机构
[1] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA
[2] Univ S Florida, Sch Informat, Tampa, FL 33620 USA
[3] Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA
[4] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China
[5] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA
基金
美国国家卫生研究院; 中国国家自然科学基金; 美国国家科学基金会;
关键词
P-GLYCOPROTEIN; THEOPHYLLINE; METABOLISM; INHIBITION; QUINIDINE;
D O I
10.1371/journal.pone.0173548
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Identifying drug-drug interaction (DDI) is an important topic for the development of safe pharmaceutical drugs and for the optimization of multidrug regimens for complex diseases such as cancer and HIV. There have been about 150,000 publications on DDIs in PubMed, which is a great resource for DDI studies. In this paper, we introduced an automatic computational method for the systematic analysis of the mechanism of DDIs using MeSH (Medical Subject Headings) terms from PubMed literature. MeSH term is a controlled vocabulary thesaurus developed by the National Library of Medicine for indexing and annotating articles. Our method can effectively identify DDI-relevant MeSH terms such as drugs, proteins and phenomena with high accuracy. The connections among these MeSH terms were investigated by using co-occurrence heatmaps and social network analysis. Our approach can be used to visualize relationships of DDI terms, which has the potential to help users better understand DDIs. As the volume of PubMed records increases, our method for automatic analysis of DDIs from the PubMed database will become more accurate.
引用
收藏
页数:13
相关论文
共 36 条
[1]   Hospitalisations and emergency department visits due to drug-drug interactions: a literature review [J].
Becker, Matthijs L. ;
Kallewaard, Marjon ;
Caspers, Peter W. J. ;
Visser, Loes E. ;
Leufkens, Hubert G. M. ;
Stricker, Bruno HCh .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (06) :641-651
[2]   Roles of rifampicin in drug-drug interactions: Underlying molecular mechanisms involving the nuclear pregnane X receptor [J].
Chen J. ;
Raymond K. .
Annals of Clinical Microbiology and Antimicrobials, 5 (1)
[3]   In vitro metabolism of cyclosporine A by human kidney CYP3A5 [J].
Dai, Y ;
Iwanaga, K ;
Lin, YS ;
Hebert, MF ;
Davis, CL ;
Huang, WL ;
Kharasch, ED ;
Thummel, KE .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (09) :1889-1902
[4]   Rifampicin treatment greatly increases the apparent oral clearance of quinidine [J].
Damkier, P ;
Hansen, LL ;
Brosen, K .
PHARMACOLOGY & TOXICOLOGY, 1999, 85 (06) :257-262
[5]   The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions [J].
DuBuske, LM .
DRUG SAFETY, 2005, 28 (09) :789-801
[6]   Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug Interactions [J].
Duke, Jon D. ;
Han, Xu ;
Wang, Zhiping ;
Subhadarshini, Abhinita ;
Karnik, Shreyas D. ;
Li, Xiaochun ;
Hall, Stephen D. ;
Jin, Yan ;
Callaghan, J. Thomas ;
Overhage, Marcus J. ;
Flockhart, David A. ;
Strother, R. Matthew ;
Quinney, Sara K. ;
Li, Lang .
PLOS COMPUTATIONAL BIOLOGY, 2012, 8 (08)
[7]  
FARRAR KT, 1985, LANCET, V1, P983
[8]   INDI: a computational framework for inferring drug interactions and their associated recommendations [J].
Gottlieb, Assaf ;
Stein, Gideon Y. ;
Oron, Yoram ;
Ruppin, Eytan ;
Sharan, Roded .
MOLECULAR SYSTEMS BIOLOGY, 2012, 8
[9]   Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network [J].
Huang, Jialiang ;
Niu, Chaoqun ;
Green, Christopher D. ;
Yang, Lun ;
Mei, Hongkang ;
Han, Jing-Dong J. .
PLOS COMPUTATIONAL BIOLOGY, 2013, 9 (03)
[10]   Drug interaction studies: Study design, data analysis, and implications for dosing and labeling [J].
Huang, S-M ;
Temple, R. ;
Throckmorton, D. C. ;
Lesko, L. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) :298-304